Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PORTHOS - PORTuguese Heart Failure Observational Study: a Nationwide Epidemiological Study on Heart Failure and Asymptomatic Left Ventricle Systolic Dysfunction Based on Contemporary Diagnostic Tools

NCT05434923 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05434923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PORTHOS - PORTuguese Heart Failure Observational Study: a Nationwide Epidemiological Study on Heart Failure and Asymptomatic Left Ventricle Systolic Dysfunction Based on Contemporary Diagnostic Tools
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2022
Completion date
September 18, 2023
Enrollment
6,189 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure